Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

SPRB

Spruce Biosciences (SPRB)

Spruce Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SPRB
FechaHoraFuenteTítuloSímboloCompañía
03/06/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
03/06/202406:00Business WireSpruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024NASDAQ:SPRBSpruce Biosciences Inc
24/05/202415:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
23/05/202415:05Business WireSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
22/05/202415:14Business WireSpruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine SocietyNASDAQ:SPRBSpruce Biosciences Inc
13/05/202415:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
13/05/202415:01Business WireSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
01/05/202415:05Business WireSpruce Biosciences to Participate in May Investor ConferencesNASDAQ:SPRBSpruce Biosciences Inc
30/04/202415:05Business WireSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
22/04/202415:05Business WireSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
13/03/202415:08Business WireSpruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
13/03/202415:01Business WireSpruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
07/03/202415:07Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
06/02/202415:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
30/01/202415:05Business WireSpruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SPRBSpruce Biosciences Inc
22/01/202407:00Business WireSpruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
05/01/202407:00Business WireSpruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
04/01/202407:00Business WireSpruce Biosciences Provides Clinical Program Updates and Outlook for 2024NASDAQ:SPRBSpruce Biosciences Inc
13/11/202315:05Business WireSpruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
02/11/202315:05Business WireSpruce Biosciences to Participate in the Jefferies London Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
18/10/202307:00Business WireSpruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
28/08/202315:00Business WireSpruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:SPRBSpruce Biosciences Inc
14/08/202315:00Business WireSpruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
12/06/202315:00Business WireSpruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)NASDAQ:SPRBSpruce Biosciences Inc
26/05/202316:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SPRBSpruce Biosciences Inc
26/05/202315:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SPRBSpruce Biosciences Inc
25/05/202307:00Business WireSpruce Biosciences Appoints Percival Barretto-Ko to Board of DirectorsNASDAQ:SPRBSpruce Biosciences Inc
24/05/202315:05Business WireSpruce Biosciences to Participate in the Jefferies Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
22/05/202308:30Business WireSpruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES GalaNASDAQ:SPRBSpruce Biosciences Inc
15/05/202307:00Business WireSpruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SPRB